The role of cytochrome P450 3A (CYP3A) isoform(s) in oxidative metabolism of testosterone and benzphetamine in human adult and fetal liver☆

https://doi.org/10.1016/0960-0760(93)90152-MGet rights and content

Abstract

Testosterone metabolism was studied in human adult and fetal liver microsomes. In fetal livers 6β-hydroxylase (6βOH) activity (1–2% of adult activity) and 2α-hydroxylase (2αOH) activity (about 40% of adult activity) were present. Also some fetal livers produced two unknown metabolites. Androstenedione was formed in all fetal livers studied (10–20% of adult activity). Testosterone hydroxylations at 6β-, 2β-, 15α and 15β-positions were associated with CYP3A isoform(s) in adult liver, because they were strongly inhibited by midazolam, a known substrate for CYP3A4 and by anti-CYP3A4 antibody. Fetal liver activities were consistently inhibited less than the activities in adult livers. The formation of androstenedione was not affected by these inhibitors in fetal or adult liver microsomes. Benzphetamine N-demethylase activity in the fetal livers was about 40% of adult activity. Anti-CYP3A4 antibody had no effect on that activity in fetal or in adult liver microsomes, whereas a monoclonal antibody 1-68-11 (generated against rat CYP2C11) slightly inhibited benzphetamine N-demethylase activity in adult liver. This study indicates that human fetal and adult liver are dissimilar in their testosterone metabolism pattern. The formation of androstenedione from testosterone in fetal liver may have a physiological role. Testosterone hydroxylases are less inhibited by anti-CYP3A4 antibody, midazolam and progesterone in fetal than in adult liver.

References (36)

  • D.J. Waxman et al.

    Regioselectivity and stereoselectivity of androgen hydroxylations catalyzed by cytochrome P-450 isozymes purified phenobarbital-induced rat liver

    J. Biol. Chem.

    (1983)
  • J. Mäenpää et al.

    Comparative studies on coumarin and testosterone metabolism in mouse and human livers: differential inhibitions by the anti-P450Coh antibody and metyrapone

    Biochem. Pharmac.

    (1991)
  • E. LeProvost et al.

    Immunological enzymatic comparison of hepatic cytochrome P450 fractions from phenobarbital, 3MC, β-naphtoflavone and 2,3,7,8 tetrachlorodibenzo p-dioxin treated rats

    Biochem. Pharmac.

    (1983)
  • F.P. Guengerich et al.

    Characterization of the rat and human microsomal cytochrome P450 forms involved in nifedipine oxidation, prototype for genetic polymorphism in oxidative drug metabolism

    J. Biol. Chem.

    (1986)
  • D.J. Waxman et al.

    Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme

    Archs Biochem. Biophys.

    (1988)
  • H. Raunio et al.

    Immunochemical and catalytical studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse

    Biochem. Pharmac.

    (1988)
  • T. Aoyama et al.

    Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine

    J. Biol. Chem.

    (1989)
  • M. Komori et al.

    Isolation of a new human fetal liver cytochrome P450 cDNA clone: Evidence for expression of a limited number of forms of cytochrome P450 in human fetal livers

    Archs Biochem. Biophys.

    (1989)

    • Cited by (0)

    ☆

    A preliminary report of this study was presented at the Third Congress of the European Society for Developmental Pharmacology, Borgholm, Sweden, 27–30 May, 1992.

    View full text
    Copyright © 1993 Published by Elsevier Ltd.